Disease-free survival | ||||||
 | Univarite analysis | Multivariate analysis | ||||
 Parameters | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value |
 Age at opetation (years old) ≤ 60 vs >  60 | 1.002 | 0.491–1.925 | 0.994 |  |  |  |
 Tumor size (mm) ≤ 20.0 vs > 20.0 | 0.924 | 0.434–2.277 | 0.850 |  |  |  |
 Skin infiltration Negative vs Positive | 2.912 | 1.302–5.883 | 0.011 | 2.518 | 1.092–5.311 | 0.032 |
 Lymph node status Negative vs Positive | 1.466 | 0.741–3.160 | 0.281 |  |  |  |
 Ki67 ≤ 14% vs > 14% | 1.413 | 0.684–3.294 | 0.367 |  |  |  |
 Objective response rate Non-Responders vs Responders | 0.157 | 0.081–0.320 | < 0.001 | 0.213 | 0.102–0.462 | < 0.001 |
 Pathological response Non-pCR vs pCR | 0.286 | 0.122–0.590 | < 0.001 | 0.427 | 0.176–0.929 | 0.031 |
 TILs Low vs High | 0.424 | 0.218–0.797 | 0.008 | 0.661 | 0.330–1.288 | 0.226 |
 Body mass index (kg/m2) ≤ 18.5 vs > 18.5 | 0.457 | 0.227–1.022 | 0.056 | 0.604 | 0.290–1.377 | 0.218 |
 Body mass index (kg/m2) ≤ 25.0 vs > 25.0 | 0.565 | 0.213–1.251 | 0.170 |  |  |  |
 Body mass index (kg/m2) ≤ 30.0 vs > 30.0 | 0.775 | 0.044–3.577 | 0.794 |  |  |  |
Overall survival | ||||||
 | Univarite analysis | Multivariate analysis | ||||
 Parameters | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value |
 Age at opetation (years old) ≤ 60 vs > 60 | 0.722 | 0.236–1.844 | 0.514 |  |  |  |
 Tumor size (mm) ≤ 20.0 vs > 20.0 | 0.836 | 0.309–2.907 | 0.752 |  |  |  |
 Skin infiltration Negative vs Positive | 4.423 | 1.675–10.643 | 0.004 | 3.957 | 1.395–10.667 | 0.011 |
 Lymph node status Negative vs Positive | 2.741 | 0.927–11.706 | 0.071 | 2.794 | 0.908–12.208 | 0.076 |
 Ki67 ≤ 14% vs > 14% | 2.090 | 0.707–8.928 | 0.199 |  |  |  |
 Objective response rate Non-Responders vs Responders | 0.088 | 0.036–0.213 | < 0.001 | 0.104 | 0.037–0.294 | < 0.001 |
 Pathological response Non-pCR vs pCR | 0.129 | 0.020–0.446 | < 0.001 | 0.246 | 0.038–0.913 | 0.035 |
 TILs Low vs High | 0.376 | 0.142–0.905 | 0.028 | 0.813 | 0.284–2.201 | 0.685 |
 Body mass index (kg/m2) ≤ 18.5 vs > 18.5 | 0.299 | 0.124–0.788 | 0.017 | 0.645 | 0.248–1.832 | 0.393 |
 Body mass index (kg/m2) ≤ 25.0 vs > 25.0 | 1.035 | 0.338–2.643 | 0.947 |  |  |  |
 Body mass index (kg/m2) ≤ 30.0 vs > 30.0 | – | – | 0.266 |  |  |  |
Disease specific survival | ||||||
 | Univarite analysis | Multivariate analysis | ||||
 Parameters | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value |
 Age at opetation (years old) ≤ 60 vs > 60 | 0.722 | 0.236–1.844 | 0.514 |  |  |  |
 Tumor size (mm) ≤ 20.0 vs > 20.0 | 0.836 | 0.309–2.907 | 0.752 |  |  |  |
 Skin infiltration Negative vs Positive | 4.423 | 1.675–10.643 | 0.004 | 3.957 | 1.395–10.667 | 0.011 |
 Lymph node status Negative vs Positive | 2.741 | 0.927–11.706 | 0.071 | 2.794 | 0.908–12.208 | 0.076 |
 Ki67 ≤ 14% vs > 14% | 2.090 | 0.707–8.928 | 0.199 |  |  |  |
 Objective response rate Non-Responders vs Responders | 0.088 | 0.036–0.213 | < 0.001 | 0.104 | 0.037–0.294 | < 0.001 |
 Pathological response Non-pCR vs pCR | 0.129 | 0.020–0.446 | < 0.001 | 0.246 | 0.038–0.913 | 0.035 |
 TILs Low vs High | 0.376 | 0.142–0.905 | 0.028 | 0.813 | 0.284–2.201 | 0.685 |
 Body mass index (kg/m2) ≤ 18.5 vs > 18.5 | 0.299 | 0.124–0.788 | 0.017 | 0.645 | 0.248–1.832 | 0.393 |
 Body mass index (kg/m2) ≤ 25.0 vs > 25.0 | 1.035 | 0.338–2.643 | 0.947 |  |  |  |
 Body mass index (kg/m2) ≤ 30.0 vs > 30.0 | – | – | 0.266 |  |  |  |